SEC Comment Letter for FIBROGEN INC (FGEN) (CIK 0000921299) (KYNB) — Feb 25, 2020
FIBROGEN INC (FGEN) (CIK 0000921299)
Date: Feb. 25, 2020 · CIK: 0000921299 · Accession: 0000000000-20-001693
AI Filing Summary & Sentiment
File numbers found in text: 001-36740
Letter
February 24, 2020 Pat Cotroneo Senior Vice President and Chief Financial Officer FIBROGEN INC 409 Illinois Street San Francisco, CA 94158 Re:FIBROGEN INC. Form 10-K for the Year Ended December 31, 2018 Filed February 27, 2019 File No. 001-36740 Dear Mr. Cotroneo: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
February 24, 2020
Pat Cotroneo
Senior Vice President and Chief Financial Officer
FIBROGEN INC
409 Illinois Street
San Francisco, CA 94158
Re:FIBROGEN INC.
Form 10-K for the Year Ended December 31, 2018
Filed February 27, 2019
File No. 001-36740
Dear Mr. Cotroneo:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences